Super with impactTM is the positive outcome HESTA creates by supporting their members to face the future with confidence, being a gutsy advocate for a fair and healthy community, and delivering investment excellence with impact. Here, they share a couple of their investments in innovative Australian medical technology companies that develop technologies to improve health and wellbeing, while delivering strong investment outcomes for their members.  

Heidi Health 

Developed and operated in Australia, Heidi Health is a medical technology company that provides a platform where patients can rapidly access the care they need and doctors have the latest tools to deliver safe, productive care. 

Heidi Health uses artificial intelligence (AI) and medical data to make every touchpoint between GP and patient a valuable one. 

HESTA is focused on investing in innovative companies like Heidi Health, that are developing the technologies and growth industries of the future to help create value and drive long-term returns for their members. 

Investments in this space also help HESTA meet their commitment to deliver super with impact by aligning with Sustainable Development Goal #3: Good Health and Well-Being. 

OncoRes Medical 

Perth-based BioMedTech startup, OncoRes Medical, is on the cusp of revolutionising breast cancer treatment. The company is developing a device that improves a surgeon’s ability to remove all the cancerous tissue during breast cancer operations. 

Through their investment in Brandon Capital, one of Australasia’s leading life science venture capital firms, HESTA is helping to advance progress in breast cancer treatment.  

OncoRes Medical’s technology was developed domestically in a collaboration between the WA Department of Health, Harry Perkins Institute and the University of Western Australia, which helps grow the local biotech sector. 

This investment also aligns with Sustainable Development Goal #3: Good Health and Well-being, and helps support jobs and innovation in sectors that many of HESTA’s members work in, alongside the opportunity to deliver promising financial outcomes for their super. 

Ready to join a top-performing super fund that’s working for real-world impact? Sign up with HESTA. 

Issued by H.E.S.T. Australia Ltd ABN 66 006 818 895 AFSL 235249, the Trustee of HESTA ABN 64 971 749 321. This information is of a general nature. It does not take into account your objectives, financial situation or specific needs so you should look at your own financial position and requirements before making a decision. You may wish to consult an adviser when doing this. The target market determination for HESTA products can be found at hesta.com.au/tmd and for HESTA for Mercy products at hestaformercy.com.au/tmd. Before making a decision about HESTA or HESTA for Mercy products you should read the relevant Product Disclosure Statement (for a copy HESTA – call 1800 813 327 or visit hesta.com.au/pds; HESTA for Mercy – call 1300 368 891 or visit hestaformercy.com.au) and consider any relevant risks (visit hesta.com.au/pds or hestaformercy.com.au/pds). © Copyright H.E.S.T. Australia Limited 2024.